Israeli patient receives new non-invasive treatment for epilepsy in first outside Europe

An Israeli patient at Clalit-Beilinson Hospital received the EASEE non-invasive brain stimulation system for epilepsy, the first use outside Europe. The device, developed by PRECISIS in Germany, stimulates the seizure focus from outside the skull. Patient Olga Moisa, 42, has had no seizures since treatment on August 31, 2026, though doctors caution it is too early to determine full effectiveness.

An Israeli patient at Clalit-Beilinson Hospital has become the first person outside Europe to receive a new non-invasive epilepsy treatment. The EASEE brain stimulation system, developed in Germany by PRECISIS, treats epilepsy without opening the skull or inserting electrodes into the brain. The first patient, 42-year-old Olga Moisa, has lived with epilepsy for 15 years and did not respond fully to medication. She received the treatment on August 31 and has not experienced any seizures since, though doctors caution it is too early to determine its full effectiveness. Dr. Idit Tamir, Director of the Functional Neurosurgery Unit, said the technology offers a genuine alternative to invasive neurostimulation for appropriately selected patients. Approximately one-third of the 100,000 people in Israel living with epilepsy do not achieve adequate seizure control through medication. The article relies on expert quotes from the medical team and the patient's son, who expressed hope that even a 50% reduction in seizures would be an improvement.